<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0235378,C0348754" disease_type="Disease or Syndrome;Injury or Poisoning" abbrv="">Hepatotoxicity</z:e> due to intravenous <z:chebi fb="0" ids="2663">amiodarone</z:chebi> (HIVAD) is a rare side effect with a distinct pattern of enzyme disturbances compared to liver damage from oral <z:chebi fb="0" ids="2663">amiodarone</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Intravenous <z:chebi fb="0" ids="2663">amiodarone</z:chebi> is administered for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> often causing <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The enzyme abnormalities and clinical setting are very similar to that of ischemic <z:hpo ids='HP_0012115'>hepatitis</z:hpo>, a far more common condition </plain></SENT>
<SENT sid="3" pm="."><plain>OBJECTIVES: To ascertain if <z:hpo ids='HP_0011009'>acute</z:hpo> HIVAD exists as a separate entity or whether reported cases may be explained by ischemic <z:hpo ids='HP_0012115'>hepatitis</z:hpo> METHODS: In this case-control retrospective study the files of hospitalized patients with markedly elevated aminotransferases were reviewed for the diagnoses of HIVAD or ischemic <z:hpo ids='HP_0012115'>hepatitis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Medline was searched for published cases of HIVAD </plain></SENT>
<SENT sid="5" pm="."><plain>Pooled data of <z:hpo ids='HP_0000001'>all</z:hpo> patients with HIVAD were compared to a control group with ischemic <z:hpo ids='HP_0012115'>hepatitis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: There were no significant differences in the clinical characteristics, laboratory results or histological findings between HIVAD and ischemic <z:hpo ids='HP_0012115'>hepatitis</z:hpo> patients </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: In our opinion, there is currently insufficient data to support the existence of distinct HIVAD, and ischemic <z:hpo ids='HP_0012115'>hepatitis</z:hpo> is a more probable diagnosis in most reported cases </plain></SENT>
<SENT sid="8" pm="."><plain>Withdrawing <z:chebi fb="0" ids="2663">amiodarone</z:chebi> because of assumed hepatic damage could deprive patients of a life-saving therapy </plain></SENT>
</text></document>